更多...
收起
This gene, a member of the cadherin superfamily, encodes one of the receptor tyrosine kinases, which are cell-surface molecules that transduce signals for cell growth and differentiation. This gene plays a crucial role in neural crest development, and it can undergo oncogenic activation in vivo and in vitro by cytogenetic rearrangement. Mutations in this gene are associated with the disorders multiple endocrine neoplasia, type IIA, multiple endocrine neoplasia, type IIB, Hirschsprung disease, and medullary thyroid carcinoma. Two transcript variants encoding different isoforms have been found for this gene. Additional transcript variants have been described but their biological validity has not been confirmed. [provided by RefSeq, Jul 2008]
[中文简述(自动翻译):]  本基因,钙粘蛋白超家族的成员,编码受体酪氨酸激酶,其是转导细胞生长和分化信号的细胞表面分子之一。此基因在神经嵴发展至关重要的作用,并且它可以在体内和由细胞遗传学重排体外经历致癌活化。在这个基因的突变与疾病多发性内分泌肿瘤症IIA型,多发性内分泌肿瘤症IIB型,先天性巨结肠病和甲状腺髓样癌相关联。已发现该基因编码不同亚型的两个转录变异体。其他转录变异体进行了说明,但其生物有效性尚未得到证实。 [由RefSeq的,2008年7月提供]
RET基因(以及对应的蛋白质)的细胞分布位置:
RET基因的本体(GO)信息:
| 疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
| Multiple Endocrine Neoplasia Type 2a | 0.613995491 | 411 | 40 | BeFree_CLINVAR_CTD_human_GAD_LHGDN_ORPHANET_UNIPROT |
| Pheochromocytoma | 0.604771993 | 143 | 14 | BeFree_CLINVAR_CTD_human_GAD_LHGDN_MGD_RGD_UNIPROT |
| Multiple Endocrine Neoplasia Type 2b | 0.591974059 | 91 | 12 | BeFree_CLINVAR_CTD_human_GAD_LHGDN_MGD_ORPHANET_UNIPROT |
| Hirschsprung Disease | 0.52854372 | 173 | 5 | BeFree_CLINVAR_CTD_human_GAD_LHGDN_ORPHANET |
| Familial medullary thyroid carcinoma | 0.521802048 | 162 | 27 | BeFree_CLINVAR_CTD_human_ORPHANET_UNIPROT |
| Medullary carcinoma of thyroid | 0.32 | 390 | 28 | BeFree_CLINVAR_CTD_human |
| Multiple Endocrine Neoplasia | 0.30480217 | 149 | 6 | BeFree_CLINVAR_CTD_human_GAD_LHGDN |
| Thyroid Neoplasm | 0.258274259 | 119 | 3 | BeFree_CTD_human_GAD_LHGDN |
| Congenital absence of kidneys syndrome | 0.241357209 | 5 | 0 | BeFree_CTD_human_ORPHANET |
| Congenital central hypoventilation | 0.241085767 | 7 | 2 | BeFree_CTD_human_UNIPROT |
| HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | 0.2 | 15 | 17 | MGD_UNIPROT |
| Papillary thyroid carcinoma | 0.179022438 | 200 | 6 | BeFree_GAD_ORPHANET |
| Medullary carcinoma | 0.157848767 | 22 | 0 | BeFree_CTD_human_GAD_LHGDN |
| Hirschsprung disease 1 | 0.156101769 | 133 | 17 | BeFree_CLINVAR |
| Neoplastic Syndromes, Hereditary | 0.125971721 | 22 | 8 | BeFree_CLINVAR |
| Burkitt Lymphoma | 0.12 | 1 | 0 | CTD_human |
| Colorectal Neoplasms | 0.12 | 2 | 0 | CTD_human |
| Status Epilepticus | 0.12 | 1 | 0 | CTD_human |
| Unilateral agenesis of kidney | 0.12 | 0 | 0 | ORPHANET |
| Amyloidosis, Familial | 0.12 | 1 | 0 | CTD_human |
| CCHS WITH HIRSCHSPRUNG DISEASE | 0.12 | 0 | 1 | CLINVAR |
| Thyroid carcinoma | 0.10871884 | 277 | 5 | BeFree_GAD |
| Brain Ischemia | 0.08 | 1 | 0 | RGD |
| Congenital clubfoot | 0.08 | 0 | 0 | MGD |
| Deafness | 0.08 | 1 | 0 | RGD |
| Parkinsonian Disorders | 0.08 | 1 | 0 | RGD |
| Paraganglioma | 0.031552066 | 29 | 1 | BeFree_GAD_LHGDN |
| Malignant neoplasm of thyroid | 0.031487257 | 116 | 2 | BeFree |
| Carcinoma, Papillary | 0.028922185 | 62 | 0 | BeFree_GAD_LHGDN |
| Adrenal Gland Neoplasms | 0.026580236 | 13 | 0 | BeFree_GAD |
| Carcinogenesis | 0.024158327 | 89 | 0 | BeFree |
| Neoplasm Metastasis | 0.018597462 | 34 | 0 | BeFree_GAD_LHGDN |
| Vesico-Ureteral Reflux | 0.01246392 | 5 | 0 | BeFree_GAD_LHGDN |
| Von Hippel-Lindau Syndrome | 0.012258492 | 21 | 2 | BeFree_GAD |
| Neuroblastoma | 0.012224816 | 36 | 0 | BeFree_LHGDN |
| Head and Neck Neoplasms | 0.01183516 | 5 | 0 | GAD |
| Malignant neoplasm of lung | 0.009620018 | 19 | 0 | BeFree_GAD |
| Central neuroblastoma | 0.009229024 | 34 | 0 | BeFree |
| Pancreatic Neoplasm | 0.008087174 | 3 | 1 | BeFree_GAD_LHGDN |
| Hyperplasia | 0.007815732 | 3 | 0 | GAD_LHGDN |
| Neoplasm Recurrence, Local | 0.007101096 | 3 | 0 | GAD |
| Adenoma | 0.006795978 | 16 | 0 | BeFree_LHGDN |
| Hashimoto Disease | 0.006263026 | 5 | 0 | BeFree_LHGDN |
| Hyperparathyroidism, Primary | 0.006253095 | 14 | 3 | BeFree_LHGDN |
| Adenocarcinoma of lung (disorder) | 0.005700279 | 21 | 0 | BeFree |
| Follicular thyroid carcinoma | 0.005157396 | 19 | 0 | BeFree |
| Secondary malignant neoplasm of lymph node | 0.005157396 | 19 | 3 | BeFree |
| Lymphatic Metastasis | 0.004734064 | 2 | 0 | GAD |
| Non-Small Cell Lung Carcinoma | 0.004614512 | 17 | 0 | BeFree |
| Hyperparathyroidism | 0.004614512 | 17 | 2 | BeFree |
| Carcinoma of lung | 0.004614512 | 17 | 0 | BeFree |
| Thyroid Nodule | 0.00434307 | 16 | 6 | BeFree |
| Adenocarcinoma | 0.003800186 | 14 | 0 | BeFree |
| Anaplastic thyroid carcinoma | 0.003800186 | 14 | 0 | BeFree |
| Thyroid Diseases | 0.003724241 | 6 | 0 | BeFree_GAD |
| Aganglionosis, Colonic | 0.003528744 | 13 | 0 | BeFree |
| Down Syndrome | 0.003452799 | 4 | 0 | BeFree_GAD |
| Nephroblastoma | 0.003267234 | 2 | 0 | BeFree_LHGDN |
| Congenital Abnormality | 0.003257302 | 12 | 0 | BeFree |
| Follicular adenoma | 0.003257302 | 12 | 0 | BeFree |
| Hypercalcemia | 0.002995792 | 2 | 0 | BeFree_LHGDN |
| Tumor Progression | 0.002985861 | 11 | 0 | BeFree |
| Inflammation | 0.00272435 | 1 | 0 | LHGDN |
| Mammary Neoplasms | 0.00272435 | 1 | 0 | LHGDN |
| Hypoventilation | 0.00272435 | 1 | 0 | LHGDN |
| melanoma | 0.002714419 | 10 | 1 | BeFree |
| Neurofibromatosis 1 | 0.002714419 | 10 | 0 | BeFree |
| Breast Carcinoma | 0.002714419 | 10 | 0 | BeFree |
| Urogenital Abnormalities | 0.002638474 | 2 | 0 | BeFree_GAD |
| Malignant neoplasm of ovary | 0.002638474 | 2 | 0 | BeFree_GAD |
| Malignant neoplasm of breast | 0.002442977 | 9 | 0 | BeFree |
| Thyroiditis | 0.002442977 | 9 | 1 | BeFree |
| Neuroendocrine Tumors | 0.002442977 | 9 | 0 | BeFree |
| Differentiated Thyroid Gland Carcinoma | 0.002442977 | 9 | 0 | BeFree |
| Papillary adenocarcinoma | 0.002367032 | 1 | 0 | GAD |
| Atherosclerosis | 0.002367032 | 1 | 0 | GAD |
| Malignant neoplasm of urinary bladder | 0.002367032 | 1 | 0 | GAD |
| Hydronephrosis | 0.002367032 | 1 | 0 | GAD |
| Hypertensive disease | 0.002367032 | 1 | 0 | GAD |
| Kidney Diseases | 0.002367032 | 1 | 0 | GAD |
| Chronic Obstructive Airway Disease | 0.002367032 | 1 | 0 | GAD |
| Neoplasms, Multiple Primary | 0.002367032 | 1 | 0 | GAD |
| Prostatic Neoplasms | 0.002367032 | 1 | 0 | GAD |
| Schizophrenia | 0.002367032 | 1 | 0 | GAD |
| Tobacco Use Disorder | 0.002367032 | 1 | 0 | GAD |
| Vitamin A Deficiency | 0.002367032 | 1 | 0 | GAD |
| Neoplasms, Second Primary | 0.002367032 | 1 | 0 | GAD |
| Urea Cycle Disorders, Inborn | 0.002367032 | 1 | 0 | GAD |
| Papillary and follicular adenocarcinoma | 0.002367032 | 1 | 0 | GAD |
| Age related macular degeneration | 0.002367032 | 1 | 0 | GAD |
| Congenital digestive system anomalies | 0.002367032 | 1 | 0 | GAD |
| Sleep Apnea, Obstructive | 0.002367032 | 1 | 0 | GAD |
| Necrotic changes (finding) | 0.002367032 | 1 | 0 | GAD |
| C-cell hyperplasia | 0.002367032 | 1 | 0 | GAD |
| THYROID CARCINOMA, SPORADIC MEDULLARY | 0.002367032 | 1 | 0 | GAD |
| Cutaneous lichen amyloidosis | 0.002367032 | 1 | 0 | GAD |
| Medullary sponge kidney disease | 0.002367032 | 1 | 0 | GAD |
| Endocrine Gland Neoplasms | 0.002171535 | 8 | 0 | BeFree |
| Multiple Endocrine Neoplasia Type 1 | 0.002171535 | 8 | 0 | BeFree |
| Hereditary Malignant Neoplasm | 0.002171535 | 8 | 0 | BeFree |
| Endocrine System Diseases | 0.001900093 | 7 | 0 | BeFree |
| Parathyroid Neoplasms | 0.001900093 | 7 | 0 | BeFree |
| Pituitary Diseases | 0.001900093 | 7 | 0 | BeFree |
| Thyroid Gland Follicular Adenoma | 0.001900093 | 7 | 0 | BeFree |
| Anaplastic carcinoma | 0.001900093 | 7 | 0 | BeFree |
| Pancreatic carcinoma | 0.001900093 | 7 | 1 | BeFree |
| Total intestinal aganglionosis | 0.001900093 | 7 | 0 | BeFree |
| Goiter | 0.001628651 | 6 | 0 | BeFree |
| Leukemia, Myelocytic, Acute | 0.001628651 | 6 | 0 | BeFree |
| Malignant neoplasm of pancreas | 0.001628651 | 6 | 1 | BeFree |
| Congenital chromosomal disease | 0.001357209 | 5 | 1 | BeFree |
| Undifferentiated carcinoma | 0.001357209 | 5 | 0 | BeFree |
| Non-Neoplastic Disorder | 0.001357209 | 5 | 0 | BeFree |
| Multiple endocrine neoplasia (MEN) Syndrome | 0.001357209 | 5 | 0 | BeFree |
| Nodular Goiter | 0.001085767 | 4 | 0 | BeFree |
| Hodgkin Disease | 0.001085767 | 4 | 0 | BeFree |
| Huntington Disease | 0.001085767 | 4 | 0 | BeFree |
| Neoplasms, Radiation-Induced | 0.001085767 | 4 | 0 | BeFree |
| Pituitary Adenoma | 0.001085767 | 4 | 0 | BeFree |
| Small cell carcinoma of lung | 0.001085767 | 4 | 0 | BeFree |
| Amyloidosis, Primary Cutaneous | 0.001085767 | 4 | 1 | BeFree |
| Congenital absence of kidney | 0.001085767 | 4 | 0 | BeFree |
| Colorectal Cancer | 0.001085767 | 4 | 0 | BeFree |
| Hyperparathyroidism-Jaw Tumor Syndrome | 0.001085767 | 4 | 0 | BeFree |
| HYPERPARATHYROIDISM 3 | 0.001085767 | 4 | 0 | BeFree |
| Anaplasia | 0.000814326 | 3 | 0 | BeFree |
| Basal Cell Nevus Syndrome | 0.000814326 | 3 | 0 | BeFree |
| Colorectal Carcinoma | 0.000814326 | 3 | 0 | BeFree |
| Ganglioneuroma | 0.000814326 | 3 | 0 | BeFree |
| leukemia | 0.000814326 | 3 | 0 | BeFree |
| Megacolon | 0.000814326 | 3 | 0 | BeFree |
| Nodule | 0.000814326 | 3 | 0 | BeFree |
| Cutaneous Melanoma | 0.000814326 | 3 | 2 | BeFree |
| Taste bitter | 0.000814326 | 3 | 0 | BeFree |
| Megacolon, not Hirschsprung's | 0.000814326 | 3 | 0 | BeFree |
| Parathyroid hyperplasia | 0.000814326 | 3 | 0 | BeFree |
| Ganglioneuromatosis | 0.000814326 | 3 | 1 | BeFree |
| Multinodular goiter | 0.000814326 | 3 | 0 | BeFree |
| Non-toxic nodular goiter | 0.000814326 | 3 | 0 | BeFree |
| Waardenburg Syndrome Type 1 | 0.000814326 | 3 | 0 | BeFree |
| Alcoholic Intoxication, Chronic | 0.000542884 | 2 | 0 | BeFree |
| Carcinoid Tumor | 0.000542884 | 2 | 0 | BeFree |
| Malignant tumor of colon | 0.000542884 | 2 | 0 | BeFree |
| Esophageal Achalasia | 0.000542884 | 2 | 0 | BeFree |
| Leukemia, Myelomonocytic, Chronic | 0.000542884 | 2 | 0 | BeFree |
| Lung Neoplasms | 0.000542884 | 2 | 0 | BeFree |
| Malignant neoplasm of stomach | 0.000542884 | 2 | 0 | BeFree |
| Melanosis | 0.000542884 | 2 | 0 | BeFree |
| Extra-Adrenal Paraganglioma | 0.000542884 | 2 | 0 | BeFree |
| Parathyroid Diseases | 0.000542884 | 2 | 2 | BeFree |
| Pituitary Neoplasms | 0.000542884 | 2 | 0 | BeFree |
| Adenomatous Polyposis Coli | 0.000542884 | 2 | 0 | BeFree |
| Skin Neoplasms | 0.000542884 | 2 | 0 | BeFree |
| Trisomy | 0.000542884 | 2 | 0 | BeFree |
| Hallopeau-Siemens Disease | 0.000542884 | 2 | 0 | BeFree |
| Benign Neoplasm | 0.000542884 | 2 | 0 | BeFree |
| Atrophic condition of skin | 0.000542884 | 2 | 0 | BeFree |
| Adenocarcinoma, Oxyphilic | 0.000542884 | 2 | 0 | BeFree |
| Adenoma, Trabecular | 0.000542884 | 2 | 0 | BeFree |
| Melanosis coli | 0.000542884 | 2 | 0 | BeFree |
| Color blindness | 0.000542884 | 2 | 0 | BeFree |
| Multiple tumors | 0.000542884 | 2 | 0 | BeFree |
| Parathyroid Adenoma | 0.000542884 | 2 | 0 | BeFree |
| Solid tumour | 0.000542884 | 2 | 0 | BeFree |
| Adenomatous goiter | 0.000542884 | 2 | 0 | BeFree |
| Carcinoid tumor no ICD-O subtype | 0.000542884 | 2 | 0 | BeFree |
| Short segment Hirschsprung's disease | 0.000542884 | 2 | 0 | BeFree |
| Neuronal intestinal dysplasia | 0.000542884 | 2 | 0 | BeFree |
| Gastrointestinal symptom | 0.000542884 | 2 | 0 | BeFree |
| Follicular neoplasm | 0.000542884 | 2 | 0 | BeFree |
| Papillary neoplasm | 0.000542884 | 2 | 0 | BeFree |
| Colon Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Stomach Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Mucosal neuromas | 0.000542884 | 2 | 0 | BeFree |
| Poorly Differentiated Thyroid Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Neural crest tumor | 0.000542884 | 2 | 0 | BeFree |
| Nonmedullary Thyroid Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Congenital Intestinal Aganglionosis | 0.000542884 | 2 | 0 | BeFree |
| Apert syndrome | 0.000271442 | 1 | 0 | BeFree |
| Primary Myelofibrosis | 0.000271442 | 1 | 0 | BeFree |
| Amyotrophic Lateral Sclerosis | 0.000271442 | 1 | 0 | BeFree |
| Supravalvular aortic stenosis | 0.000271442 | 1 | 0 | BeFree |
| Brain Neoplasms | 0.000271442 | 1 | 0 | BeFree |
| Developmental Disabilities | 0.000271442 | 1 | 0 | BeFree |
| Constipation | 0.000271442 | 1 | 0 | BeFree |
| Cyst | 0.000271442 | 1 | 0 | BeFree |
| Gastrointestinal Diseases | 0.000271442 | 1 | 0 | BeFree |
| Glomus Tumor | 0.000271442 | 1 | 0 | BeFree |
| HSAN Type IV | 0.000271442 | 1 | 0 | BeFree |
| Hypothyroidism | 0.000271442 | 1 | 1 | BeFree |
| insulinoma | 0.000271442 | 1 | 0 | BeFree |
| Kidney Failure, Chronic | 0.000271442 | 1 | 0 | BeFree |
| Myeloid Leukemia, Chronic | 0.000271442 | 1 | 0 | BeFree |
| liposarcoma | 0.000271442 | 1 | 0 | BeFree |
| Lupus Erythematosus, Systemic | 0.000271442 | 1 | 0 | BeFree |
| Medulloblastoma | 0.000271442 | 1 | 0 | BeFree |
| Myeloproliferative disease | 0.000271442 | 1 | 0 | BeFree |
| nervous system disorder | 0.000271442 | 1 | 0 | BeFree |
| Neurilemmoma | 0.000271442 | 1 | 0 | BeFree |
| Parkinson Disease | 0.000271442 | 1 | 0 | BeFree |
| Peripheral Neuropathy | 0.000271442 | 1 | 0 | BeFree |
| Precancerous Conditions | 0.000271442 | 1 | 1 | BeFree |
| Seminoma | 0.000271442 | 1 | 0 | BeFree |
| Skin nodule | 0.000271442 | 1 | 0 | BeFree |
| Struma Ovarii | 0.000271442 | 1 | 0 | BeFree |
| Substance Dependence | 0.000271442 | 1 | 0 | BeFree |
| Werner Syndrome | 0.000271442 | 1 | 0 | BeFree |
| Pleural Effusion, Malignant | 0.000271442 | 1 | 0 | BeFree |
| Severe Combined Immunodeficiency | 0.000271442 | 1 | 0 | BeFree |
| Malignant neoplasm of mouth | 0.000271442 | 1 | 0 | BeFree |
| Malignant neoplasm of brain | 0.000271442 | 1 | 0 | BeFree |
| Malignant tumor of parathyroid gland | 0.000271442 | 1 | 0 | BeFree |
| Germ cell tumor | 0.000271442 | 1 | 0 | BeFree |
| Liposarcoma, Myxoid | 0.000271442 | 1 | 0 | BeFree |
| Alveolar Soft Part Sarcoma | 0.000271442 | 1 | 0 | BeFree |
| Lip and Oral Cavity Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Turcot syndrome (disorder) | 0.000271442 | 1 | 0 | BeFree |
| Autosomal dominant hereditary disorder | 0.000271442 | 1 | 0 | BeFree |
| Congenital anomaly of the kidney | 0.000271442 | 1 | 0 | BeFree |
| Familial lichen amyloidosis | 0.000271442 | 1 | 0 | BeFree |
| metastatic parathyroid cancer | 0.000271442 | 1 | 1 | BeFree |
| secondary acute myeloid leukemia | 0.000271442 | 1 | 0 | BeFree |
| Adenocarcinoma of pancreas | 0.000271442 | 1 | 0 | BeFree |
| Dermatitis verrucosa | 0.000271442 | 1 | 0 | BeFree |
| Inflammatory Myofibroblastic Tumor | 0.000271442 | 1 | 0 | BeFree |
| Psammomatous Meningioma | 0.000271442 | 1 | 0 | BeFree |
| Early gastric cancer | 0.000271442 | 1 | 0 | BeFree |
| Hematopoietic Neoplasms | 0.000271442 | 1 | 0 | BeFree |
| Hematologic Neoplasms | 0.000271442 | 1 | 0 | BeFree |
| Primary vesicoureteric reflux | 0.000271442 | 1 | 1 | BeFree |
| Carney Complex | 0.000271442 | 1 | 0 | BeFree |
| Mandibuloacral dysostosis | 0.000271442 | 1 | 0 | BeFree |
| Secondary malignant neoplasm of liver | 0.000271442 | 1 | 1 | BeFree |
| Benign neurologic neoplasms | 0.000271442 | 1 | 0 | BeFree |
| Progressive Neoplastic Disease | 0.000271442 | 1 | 0 | BeFree |
| Stage II Colorectal Cancer | 0.000271442 | 1 | 0 | BeFree |
| Parathyroid Gland Adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
| Carcinoma of bladder | 0.000271442 | 1 | 0 | BeFree |
| thyroid nodule solitary | 0.000271442 | 1 | 0 | BeFree |
| trisomy 2 | 0.000271442 | 1 | 0 | BeFree |
| MARDEN-WALKER SYNDROME | 0.000271442 | 1 | 0 | BeFree |
| Malignant Pleural Mesothelioma | 0.000271442 | 1 | 0 | BeFree |
| Rhabdoid Tumor of the Kidney | 0.000271442 | 1 | 0 | BeFree |
| Adenocarcinoma of lung, stage IV | 0.000271442 | 1 | 0 | BeFree |
| Intraepithelial Neoplasia | 0.000271442 | 1 | 0 | BeFree |
| Autoimmune thyroiditis | 0.000271442 | 1 | 0 | BeFree |
| cancer recurrence | 0.000271442 | 1 | 0 | BeFree |
| Chromosome 17 trisomy | 0.000271442 | 1 | 0 | BeFree |
| Pheochromocytoma, Extra-Adrenal | 0.000271442 | 1 | 0 | BeFree |
| Papillary microcarcinoma | 0.000271442 | 1 | 0 | BeFree |
| Chronic myeloproliferative disorder | 0.000271442 | 1 | 0 | BeFree |
| Single tumor | 0.000271442 | 1 | 0 | BeFree |
| Adenocarcinoma of large intestine | 0.000271442 | 1 | 0 | BeFree |
| Desmoplastic melanoma | 0.000271442 | 1 | 0 | BeFree |
| Paragangliomas, head and neck | 0.000271442 | 1 | 0 | BeFree |
| Neuroblastic Tumor | 0.000271442 | 1 | 0 | BeFree |
| Thyroid Hyalinizing Trabecular Adenoma | 0.000271442 | 1 | 0 | BeFree |
| Drug Dependence | 0.000271442 | 1 | 0 | BeFree |
| Benign Struma Ovarii | 0.000271442 | 1 | 0 | BeFree |
| Malignant Conversion | 0.000271442 | 1 | 0 | BeFree |
| Xenograft Model | 0.000271442 | 1 | 0 | BeFree |
| RENAL ADYSPLASIA | 0.000271442 | 1 | 0 | BeFree |
| androgen independent prostate cancer | 0.000271442 | 1 | 0 | BeFree |
| Neonatal Deformity | 0.000271442 | 1 | 0 | BeFree |
| Hereditary Paraganglioma-Pheochromocytoma Syndrome | 0.000271442 | 1 | 0 | BeFree |
| Bulbo-Spinal Atrophy, X-Linked | 0.000271442 | 1 | 0 | BeFree |
| WAARDENBURG SYNDROME, TYPE 4A | 0.000271442 | 1 | 0 | BeFree |
| MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA | 0.000271442 | 1 | 0 | BeFree |
| PITUITARY ADENOMA PREDISPOSITION (disorder) | 0.000271442 | 1 | 0 | BeFree |
| Liver carcinoma | 0.000271442 | 1 | 0 | BeFree |
| aggressive cancer | 0.000271442 | 1 | 0 | BeFree |
| Stage II Colorectal Cancer AJCC v7 | 0.000271442 | 1 | 0 | BeFree |
| Progressive cGVHD | 0.000271442 | 1 | 0 | BeFree |
| Experimental Organism Basal Cell Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Papillary carcinoma of the breast | 0.000271442 | 1 | 0 | BeFree |
忘记密码? 点击找回密码.
扫一扫右方二维码,关注微信订阅号,实时查看信息,关注医学生物学动态。